Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
about
Clinical utility of serum biomarkers in Duchenne muscular dystrophy204th ENMC International Workshop on Biomarkers in Duchenne Muscular Dystrophy 24-26 January 2014, Naarden, The NetherlandsAffinity Proteomics Exploration of Melanoma Identifies Proteins in Serum with Associations to T-Stage and Recurrence.Proteomic profiling of mdx-4cv serum reveals highly elevated levels of the inflammation-induced plasma marker haptoglobin in muscular dystrophy.The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseasesLarge-scale serum protein biomarker discovery in Duchenne muscular dystrophyMeeting Report: New Directions in the Biology and Disease of Skeletal Muscle 2014Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies.Enhanced Muscular Dystrophy from Loss of Dysferlin Is Accompanied by Impaired Annexin A6 Translocation after Sarcolemmal Disruption.Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study.Increased Levels of Extracellular Microvesicle Markers and Decreased Levels of Endocytic/Exocytic Proteins in the Alzheimer's Disease Brain.Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics.Immunocapture strategies in translational proteomics.Serum Levels of MicroRNA-206 and Novel Mini-STR Assays for Carrier Detection in Duchenne Muscular Dystrophy.Affinity proteomics discovers decreased levels of AMFR in plasma from Osteoporosis patients.Concurrent Label-Free Mass Spectrometric Analysis of Dystrophin Isoform Dp427 and the Myofibrosis Marker Collagen in Crude Extracts from mdx-4cv Skeletal Muscles.Looking Forward to New Therapies: A Personal Perspective on the Translational Landscape for Muscular Dystrophies.Circulating Biomarkers for Duchenne Muscular Dystrophy.Identification of serum protein biomarkers for utrophin based DMD therapy.Muscle-Derived Proteins as Serum Biomarkers for Monitoring Disease Progression in Three Forms of Muscular Dystrophy.A Highlight of Recent Advances in Aptamer Technology and Its Application.Pathoproteomic profiling of the skeletal muscle matrisome in dystrophinopathy associated myofibrosis.Neuroproteomic profiling of human body fluids.Interleukin 1 Receptor-Like 1 Protein (ST2) is a Potential Biomarker for Cardiomyopathy in Duchenne Muscular Dystrophy.Mass spectrometry-based protein analysis to unravel the tissue pathophysiology in Duchenne muscular dystrophy.Progressive muscle proteome changes in a clinically relevant pig model of Duchenne muscular dystrophy.Assessing the translational landscape of myogenic differentiation by ribosome profiling.Reduced serum myostatin concentrations associated with genetic muscle disease progression.Label-free mass spectrometric analysis of the mdx-4cv diaphragm identifies the matricellular protein periostin as a potential factor involved in dystrophinopathy-related fibrosis.Progress toward Gene Therapy for Duchenne Muscular Dystrophy.Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients.Non-Invasive Biomarkers for Duchenne Muscular Dystrophy and Carrier Detection.Multiplexed protein profiling by sequential affinity capture.Neo-epitope Peptides as Biomarkers of Disease Progression for Muscular Dystrophies and Other Myopathies.The International Rare Diseases Research Consortium: Policies and Guidelines to maximize impact.MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide.Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne.226th ENMC International Workshop:: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20-22 January 2017, Heemskerk, The Netherlands.Bead-Based and Multiplexed Immunoassays for Protein Profiling via Sequential Affinity Capture.Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density.
P2860
Q26751261-D8F97955-BA5D-4D9A-8C45-D7BC88A27E06Q28611318-7995A66A-AB4C-4B8E-AC18-71DA55C6F63BQ33599603-1C01912C-2238-4C0A-BE63-FC50A1A723B3Q33675040-9E72FDE4-22AA-4CDD-901C-171F85CAF803Q34042850-E128F64A-F616-49AF-B344-40B3A587E8EEQ35740280-A2B04259-9332-4B21-8C54-68C50CB758D3Q35869849-493BDEAE-2307-451B-8A43-619BCF0FDD24Q35924068-11F92F6A-C0E1-4B91-AB28-6FD0FF29C0C2Q35987272-087D74F1-9D6D-4939-8843-616E59B3B063Q35991086-20736746-1957-4F3B-98A3-BF84FB46C1BAQ36135752-33A8A7CF-BADD-4C48-8411-144F95FB2BF5Q36305436-F1A322B4-7A3A-42A6-99EA-622274758348Q36519000-359EFC25-E5DD-4B53-A1C8-26E38E7D0D3FQ37210178-8A558935-DF8E-4351-99B2-652A3000B6E9Q37268854-F83B1EBB-B100-435A-83AC-0E7BECD56569Q37566483-36F7B800-6A77-4BC1-9761-E301C9B29877Q37589787-644A7BD4-F3DC-4B15-9E6D-BDC2746F8D7BQ37610530-C06BF282-013F-4B02-BD45-BF292FFF086FQ37676311-3F4D9279-569E-4E4B-BA84-50D4152CDE21Q38302852-1CD88DE0-740A-436E-844D-51FF1B898930Q38541697-5A280405-B991-4DDD-A81C-3990411F937CQ38563300-E153F870-3A74-4F0C-B5AC-91566ACFB083Q38569255-5D998BC5-7341-4DC1-BEE3-FAEF537F068DQ38640186-11EAB4A4-5999-480C-ABC3-216668620BF5Q38717697-2020A791-526D-4A67-9978-CE1C18B7AC3CQ38820669-0BB21EA0-528C-4289-B8EB-3D180A43DFDCQ38887219-F780825B-E367-46E3-B055-68E19D77BFF6Q39028061-82429CA7-0804-4A8F-A2F1-32010AA6586BQ39033229-3CDFC397-7640-43DB-8D12-3404EA13187CQ39246797-269D0C20-29F8-4BBB-A03B-8A7A0FCD27B5Q40198410-4475D4EF-7720-49DB-B567-4DFB63F6A8A8Q40820281-8FDF1794-65C2-40B9-9728-DA8A75ACDDF2Q41512772-3571634E-580E-411A-90A1-20CC29E8AA7AQ42363358-01260A59-3DD5-4944-89DA-0946094F87B5Q45951485-28B6868F-DA8F-453A-8864-9AEF009B39BFQ47103310-0612B8B5-4E32-41E3-B49A-5F33882A3640Q47115483-D31575AD-8A9A-411F-80B3-35FB1192074BQ48543939-9FE35981-0A5A-40CE-8DD7-DB2CFC6C3027Q48733575-857C7613-6498-43C1-A529-538042A3ADD4Q49416704-93A36129-CB02-438E-9F81-686063A74CB8
P2860
Affinity proteomics within rare diseases: a BIO-NMD study for blood biomarkers of muscular dystrophies
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Affinity proteomics within rar ...... arkers of muscular dystrophies
@ast
Affinity proteomics within rar ...... arkers of muscular dystrophies
@en
type
label
Affinity proteomics within rar ...... arkers of muscular dystrophies
@ast
Affinity proteomics within rar ...... arkers of muscular dystrophies
@en
altLabel
Affinity proteomics within rar ...... arkers of muscular dystrophies
@en
prefLabel
Affinity proteomics within rar ...... arkers of muscular dystrophies
@ast
Affinity proteomics within rar ...... arkers of muscular dystrophies
@en
P2093
P2860
P50
P356
P1476
Affinity proteomics within rar ...... arkers of muscular dystrophies
@en
P2093
Alessandra Ferlini
Amina Chaouch
Burcu Ayoglu
Elena Schwartz
Francesca Gualandi
Francesco Muntoni
Kate Bushby
Luisa Politano
Monika Hiller
Sebahattin Cirak
P2860
P304
P356
10.15252/EMMM.201303724
P50
P577
2014-06-11T00:00:00Z